- CRS Publications
- News
News
Authors:
Date:
PRNewswire: August 29, 2017 – SAN DIEGO, CA, U.S.A. – Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (“Sorrento”), announced today that Scilex Pharmaceuticals Inc. (“Scilex”), a majority-owned subsidiary of Sorrento, resubmitted the NDA and responded to all of FDA comments related to the initial NDA…
Authors:
Date:
PRNewswire: August 24, 2017 – SOUTH SAN FRANCISCO, CA, U.S.A. – Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for its ropinirole implant intended for treatment of the signs and…
Authors:
Date:
PRNewswire: August 24, 2017 – BOONTON, NJ, U.S.A. – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, announced today that the first woman has been dosed in its phase 2a clinical trial to evaluate Ovarest™, an…
Authors:
Date:
PRNewswire: August 24, 2017 – WILSON, WY, U.S.A. – SynAgile Corporation (www.synagile.com), a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse™ technology platform, today announced the closing of a $10.4 million round of…
Date:
PRNewswire: August 23, 2017 – RALEIGH, NC, U.S.A. – BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that at the end of 2017, Dr. Mark A. Sirgo will retire as BDSI’s president and chief executive officer, roles which he has held since 2005. Dr. Sirgo will remain as vice…
Authors:
Date:
PRNewswire: August 22, 2017 – SAN JOSE, CA, U.S.A. – Teikoku Pharma USA, Inc. (Teikoku Pharma) today announced positive topline results from its phase 2 proof of concept study of TPU-006, a 3-day dexmedetomidine transdermal patch, a novel drug delivery system with a nonopioid active moiety for the…
